logo

For the Inventor, By the Inventor

Easton, PA, United States of America

Anthony Frank

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal9 out of 549 
 
Celgene Corporation
 patents
silverMedal2 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents

Years Active: 2013-2020

Loading Chart...
11 patents (USPTO):Explore Patents
1. 10604510 - Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereof (2020-03-31),
2. 9688623 - Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine (2017-06-27),
3. 9642836 - Isotopologues of isoindole derivatives (2017-05-09),
4. 9586897 - Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine (2017-03-07),
5. 9198866 - Pharmaceutical formulations of a substituted diaminopurine (2015-12-01),
6. 9187417 - Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine (2015-11-17),
7. 9045417 - Isotopologues of isoindole derivatives (2015-06-02),
8. 8853175 - Phenethylsulfone isoindoline derivatives and their use (2014-10-07),
9. 8716252 - (Methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses (2014-05-06),
10. 8603527 - Pharmaceutical formulations of a substituted diaminopurine (2013-12-10),
11. 8415485 - Processes for the preparation of 2-(1-phenylethyl)isoindolin-1-one compounds (2013-04-09),

Title: Anthony Frank: Innovator in Pharmaceutical Chemistry

Introduction

Anthony Frank is a notable inventor based in Easton, PA (US), recognized for his contributions to pharmaceutical chemistry. With a total of 11 patents, he has made significant strides in the development of innovative compounds and processes that have the potential to treat various diseases, including cancer.

Latest Patents

Among his latest patents, Anthony Frank has developed solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxamide. This invention includes compositions featuring crystalline forms of 'Compound A', methods for their preparation, and their applications in treating diseases such as cancer. Additionally, he has patented processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine, which are crucial for synthesizing intermediates that can help prevent or treat conditions related to elevated TNF-α levels.

Career Highlights

Anthony Frank has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His work in these organizations has allowed him to contribute to the advancement of medical science through innovative research and development.

Collaborations

Throughout his career, Anthony has collaborated with esteemed colleagues such as Hon-Wah Man and Jasti Venkateswaralu. These partnerships have further enriched his research and have led to the successful development of various pharmaceutical innovations.

Conclusion

Anthony Frank's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…